Lundbeckfonden

Lundbeckfonden

Lundbeckfonden

Lundbeckfonden er en erhvervsdrivende fond, stiftet i 1954, hvis hovedformål er at sikre og udbygge Lundbeck-koncernens virksomhed og yde finansiel støtte til videnskabelig forskning af høj kvalitet.
Founded
1954
Follow us
€46,300,000 Venture capital (Series E)
FinSMEs

Enterome Closes €46.3M Financing Round

the home of AI info

scPharmaceuticals Inc. (SCPH) and Minerva Neurosciences Inc. (NASDAQ:NERV) Comparing ...

MedCity News

DBV Technologies' peanut allergy patch gets FDA review

€32,000,000 Venture capital (Series D)
PE HUB , FinSMEs

| Enterome lands Series D funding

Health Funding Science
$89,600,000 IPO
PE HUB

VC-backed scPharmaceuticals rakes in almost $90 mln for IPO

Stock markets Funding Privacy
PE HUB

VC-backed Spero Therapeutics sets IPO pricing terms

Stock markets Funding
PE HUB

VC-backed Spero Therapeutics files for IPO

Stock markets Health Funding
Xconomy

Cydan, NEA’s Orphan Drug Experiment, Pays Off in $200M Vtesse Deal

Health
$51,700,000 Venture capital (Series C)
Spero Therapeutics

Spero Therapeutics Secures $51.7 Million in Oversubscribed Series C Financing

Xconomy

Google’s Venture Arm Leads $51.7M Investment in Spero Therapeutics

Funding Health
$45,600,000 Venture capital (Series B)
vcaonline

Venture Capital Access Online | Venture Capital News

Venture capital
prnewswire

BONESUPPORT™ Raises $37 Million (SEK 327 million) to Drive Product Sales and Deliver Further Value /PR Newswire UK/

$10,000,000 Venture capital (Series C)
FinSMEs , PE Hub

Iconic Therapeutics Closes $10M Series C Financing

Funding Health
$17,000,000 Venture capital (Series A)
FierceBiotech , vcaonline

Pfizer, NEA-backed rare disease startup bumps up Series A to $42M

Health Funding Science
Xconomy

Spero Rolls up More Antibiotics With Vertex Deal

Health
€14,500,000 Venture capital (Series C)
FinSMEs

Enterome Bioscience Raises €14.5M in Series C Funding

Health Funding
Xconomy

Spero Eyes First Trial, Gets $30M More to Battle Drug-Resistant Bugs

Health Funding
$30,000,000 Venture capital (Series B)
FinSMEs

Spero Therapeutics Raised $30M in Series B Funding

Health Funding
$40,000,000 Venture capital (Series C)
FinSMEs

Iconic Therapeutics Closes $40M Series C Financing

Health Funding
$25,500,000 Venture capital (Series C)
VentureWire

DBV Technologies Raises $25.5M Series C For Peanut Allergy Patch